Los Angeles, CA – June 12, 2025 - The Terasaki Institute for Biomedical Innovation (TIBI) is proud to be featured in Cell Biomaterials by Cell Press, highlighting key moments and insights from our 2025 Terasaki Innovation Summit. The article captures powerful reflections from world-renowned leaders in bioengineering, regenerative medicine, AI-powered healthcare, and translational science, all united by a shared mission to advance human health through innovation.
Los Angeles, CA – June 10, 2025 - The Terasaki Institute for Biomedical Innovation is proud to announce that its CEO and Director, Dr. Ali Khademhosseini, has been recognized as one of the world’s top scientists in the field of Materials Science by Research.com. In their recently released 2025 rankings, Dr. Khademhosseini was placed in the 41st position globally and 21st in the United States. In addition to these rankings, he has also been awarded Research.com’s prestigious Materials Science Leader Award for 2025.
Los Angeles, CA – May 29, 2025 - The Terasaki Institute for Biomedical Innovation (TIBI) and California State University, Northridge (CSUN) are proud to announce the launch of a new collaboration initiative that brings advanced hands-on laboratory experience to CSUN Biology graduate students as part of their curriculum.
Los Angeles, CA - May 22, 2025 – Scientists at the Terasaki Institute for Biomedical Innovation (TIBI), led by Dr. Vadim Jucaud (Assistant Professor), have engineered a novel multi-cellular 3D glioblastoma (GBM) in vitro model that mimics the biomechanical properties of brain tissue and the role of pericytes in glioblastoma (GBM) resistance to temozolomide (TMZ), the standard-of-care chemotherapy for this deadly brain cancer.
LOS ANGELES, May 13. 2025 – Researchers at the Terasaki Institute for Biomedical Innovation (TIBI) have developed a technique that could help advance treatments in tissue engineering. The study, published in the scientific journal Small, introduces a technique for producing tissues with precise cellular organization designed to mimic the natural structure of human tissue.
LOS ANGELES, April 28. 2025 – In a breakthrough that could redefine the future of wearable technology, scientists at the Terasaki Institute for Biomedical Innovation have developed an electronic skin that can heal itself within just 10 seconds of being damaged. This cutting-edge material, which maintains both flexibility and electrical performance after repeated wear and tear, overcomes one of the biggest challenges in wearable electronics — and could soon power next-generation health monitoring devices. The team’s findings appear in a new study titled: “Rapid Self-Healing Electronic Skin for Real-Time Biosignal Monitoring.”
LOS ANGELES, April 23, 2025 — The Terasaki Institute for Biomedical Innovation (TIBI) proudly announces that its Director and CEO, Dr. Ali Khademhosseini, has received the 2025 Materials Research Society (MRS) Mid-Career Researcher Award. This prestigious honor recognizes exceptional achievements in materials research by mid-career professionals who have demonstrated notable leadership in the field.
(WOODLAND HILLS, CA) – April 9th, 2025 – Scientists at Terasaki Institute for Biomedical Innovation, in collaboration with the University of Maryland School of Pharmacy, have developed a new nanoparticle therapy that tackles obesity through two complementary mechanisms: converting energy-storing white fat into calorie-burning beige fat while simultaneously reducing obesity-related inflammation. Their findings, published in the Journal of Controlled Release, are detailed in an article titled: “Apigenin-loaded nanoparticles for obesity intervention through immunomodulation and adipocyte browning.” This innovative approach addresses key limitations of current obesity treatments by precisely targeting adipose tissue with apigenin-loaded nanoparticles - enhancing therapeutic effects while minimizing potential side effects. A link to the article can be found here.